Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
Open Access
- 6 August 2022
- journal article
- review article
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 8 (2) , e10381
Abstract
Antibiotic resistance ranks among the top threats to humanity. Due to the frequent use of antibiotics, society is facing a high prevalence of multidrug resistant pathogens, which have managed to evolve mechanisms that help them evade the last line of therapeutics. An alternative to antibiotics could involve the use of bacteriophages (phages), which are the natural predators of bacterial cells. In earlier times, phages were implemented as therapeutic agents for a century but were mainly replaced with antibiotics, and considering the menace of antimicrobial resistance, it might again become of interest due to the increasing threat of antibiotic resistance among pathogens. The current understanding of phage biology and clustered regularly interspaced short palindromic repeats (CRISPR) assisted phage genome engineering techniques have facilitated to generate phage variants with unique therapeutic values. In this review, we briefly explain strategies to engineer bacteriophages. Next, we highlight the literature supporting CRISPR‐Cas9‐assisted phage engineering for effective and more specific targeting of bacterial pathogens. Lastly, we discuss techniques that either help to increase the fitness, specificity, or lytic ability of bacteriophages to control an infection.Keywords
Funding Information
- Indian Council of Medical Research (5/3/8/41/ITR‐F/2022‐ITR, 5/3/8/63/ITR‐F/2020)
- National Research Foundation of Korea (2018M3A9B5024066, 2021M3A9H3015389, 2021R1I1A1A01049524)
This publication has 173 references indexed in Scilit:
- A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistanceBMC Infectious Diseases, 2014
- Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan AfricaNature Genetics, 2012
- Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus ChallengePLOS ONE, 2012
- RecombineeringBacteriophage, 2012
- Adaptive laboratory evolution — harnessing the power of biology for metabolic engineeringCurrent Opinion in Biotechnology, 2011
- Phage treatment of human infectionsBacteriophage, 2011
- Beyond directed evolution—semi-rational protein engineering and designCurrent Opinion in Biotechnology, 2010
- Origins and Evolution of Antibiotic ResistanceMicrobiology and Molecular Biology Reviews, 2010
- A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the FutureFrontiers in Microbiology, 2010
- BRED: A Simple and Powerful Tool for Constructing Mutant and Recombinant Bacteriophage GenomesPLOS ONE, 2008